Table of Content

1 Venom Antiserum Market Overview
1.1 Product Overview and Scope of Venom Antiserum
1.2 Venom Antiserum Segment by Type
1.2.1 Global Venom Antiserum Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Polyvalent
1.2.3 Monovalent
1.3 Venom Antiserum Segment by Application
1.3.1 Venom Antiserum Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals and Clinics
1.3.3 Non-profit Institutions
1.4 Global Venom Antiserum Market Size Estimates and Forecasts
1.4.1 Global Venom Antiserum Revenue 2016-2027
1.4.2 Global Venom Antiserum Sales 2016-2027
1.4.3 Venom Antiserum Market Size by Region: 2016 Versus 2021 Versus 2027

2 Venom Antiserum Market Competition by Manufacturers
2.1 Global Venom Antiserum Sales Market Share by Manufacturers (2016-2021)
2.2 Global Venom Antiserum Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Venom Antiserum Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Venom Antiserum Manufacturing Sites, Area Served, Product Type
2.5 Venom Antiserum Market Competitive Situation and Trends
2.5.1 Venom Antiserum Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Venom Antiserum Players Market Share by Revenue
2.5.3 Global Venom Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Venom Antiserum Retrospective Market Scenario by Region
3.1 Global Venom Antiserum Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Venom Antiserum Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Venom Antiserum Market Facts & Figures by Country
3.3.1 North America Venom Antiserum Sales by Country
3.3.2 North America Venom Antiserum Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Venom Antiserum Market Facts & Figures by Country
3.4.1 Europe Venom Antiserum Sales by Country
3.4.2 Europe Venom Antiserum Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Venom Antiserum Market Facts & Figures by Region
3.5.1 Asia Pacific Venom Antiserum Sales by Region
3.5.2 Asia Pacific Venom Antiserum Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Venom Antiserum Market Facts & Figures by Country
3.6.1 Latin America Venom Antiserum Sales by Country
3.6.2 Latin America Venom Antiserum Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Venom Antiserum Market Facts & Figures by Country
3.7.1 Middle East and Africa Venom Antiserum Sales by Country
3.7.2 Middle East and Africa Venom Antiserum Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Venom Antiserum Historic Market Analysis by Type
4.1 Global Venom Antiserum Sales Market Share by Type (2016-2021)
4.2 Global Venom Antiserum Revenue Market Share by Type (2016-2021)
4.3 Global Venom Antiserum Price by Type (2016-2021)

5 Global Venom Antiserum Historic Market Analysis by Application
5.1 Global Venom Antiserum Sales Market Share by Application (2016-2021)
5.2 Global Venom Antiserum Revenue Market Share by Application (2016-2021)
5.3 Global Venom Antiserum Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 BTG
6.3.1 BTG Corporation Information
6.3.2 BTG Description and Business Overview
6.3.3 BTG Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.3.4 BTG Product Portfolio
6.3.5 BTG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Haffkine Bio-Pharmaceutical Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Rare Disease Therapeutics
6.6.1 Rare Disease Therapeutics Corporation Information
6.6.2 Rare Disease Therapeutics Description and Business Overview
6.6.3 Rare Disease Therapeutics Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Rare Disease Therapeutics Product Portfolio
6.6.5 Rare Disease Therapeutics Recent Developments/Updates
6.7 Flynn Pharma
6.6.1 Flynn Pharma Corporation Information
6.6.2 Flynn Pharma Description and Business Overview
6.6.3 Flynn Pharma Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Flynn Pharma Product Portfolio
6.7.5 Flynn Pharma Recent Developments/Updates
6.8 Vins Bioproducts
6.8.1 Vins Bioproducts Corporation Information
6.8.2 Vins Bioproducts Description and Business Overview
6.8.3 Vins Bioproducts Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Vins Bioproducts Product Portfolio
6.8.5 Vins Bioproducts Recent Developments/Updates
6.9 Bharat Serums and Vaccines
6.9.1 Bharat Serums and Vaccines Corporation Information
6.9.2 Bharat Serums and Vaccines Description and Business Overview
6.9.3 Bharat Serums and Vaccines Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bharat Serums and Vaccines Product Portfolio
6.9.5 Bharat Serums and Vaccines Recent Developments/Updates
6.10 Serum Biotech
6.10.1 Serum Biotech Corporation Information
6.10.2 Serum Biotech Description and Business Overview
6.10.3 Serum Biotech Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Serum Biotech Product Portfolio
6.10.5 Serum Biotech Recent Developments/Updates
6.11 MicroPharm
6.11.1 MicroPharm Corporation Information
6.11.2 MicroPharm Venom Antiserum Description and Business Overview
6.11.3 MicroPharm Venom Antiserum Sales, Revenue and Gross Margin (2016-2021)
6.11.4 MicroPharm Product Portfolio
6.11.5 MicroPharm Recent Developments/Updates

7 Venom Antiserum Manufacturing Cost Analysis
7.1 Venom Antiserum Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Venom Antiserum
7.4 Venom Antiserum Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Venom Antiserum Distributors List
8.3 Venom Antiserum Customers

9 Venom Antiserum Market Dynamics
9.1 Venom Antiserum Industry Trends
9.2 Venom Antiserum Growth Drivers
9.3 Venom Antiserum Market Challenges
9.4 Venom Antiserum Market Restraints

10 Global Market Forecast
10.1 Venom Antiserum Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Venom Antiserum by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Venom Antiserum by Type (2022-2027)
10.2 Venom Antiserum Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Venom Antiserum by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Venom Antiserum by Application (2022-2027)
10.3 Venom Antiserum Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Venom Antiserum by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Venom Antiserum by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Venom Antiserum Sales (K Vials) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Venom Antiserum Sales (K Vials) Comparison by Application (2021-2027)
Table 3. Global Venom Antiserum Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Venom Antiserum Covered in This Study
Table 5. Global Venom Antiserum Sales (K Vials) of Key Manufacturers (2016-2021)
Table 6. Global Venom Antiserum Sales Share by Manufacturers (2016-2021)
Table 7. Global Venom Antiserum Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Venom Antiserum Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Venom Antiserum Average Price (USD/Vial) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Venom Antiserum Manufacturing Sites and Area Served
Table 11. Manufacturers Venom Antiserum Product Type
Table 12. Global Venom Antiserum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Venom Antiserum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venom Antiserum as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Venom Antiserum Sales by Region (2016-2021) & (K Vials)
Table 16. Global Venom Antiserum Sales Market Share by Region (2016-2021)
Table 17. Global Venom Antiserum Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Venom Antiserum Sales by Country (2016-2021) & (K Vials)
Table 19. North America Venom Antiserum Sales Market Share by Country (2016-2021)
Table 20. North America Venom Antiserum Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Venom Antiserum Revenue Market Share by Country (2016-2021)
Table 22. Europe Venom Antiserum Sales by Country (2016-2021) & (K Vials)
Table 23. Europe Venom Antiserum Sales Market Share by Country (2016-2021)
Table 24. Europe Venom Antiserum Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Venom Antiserum Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Venom Antiserum Sales by Region (2016-2021) & (K Vials)
Table 27. Asia Pacific Venom Antiserum Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Venom Antiserum Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Venom Antiserum Revenue Market Share by Region (2016-2021)
Table 30. Latin America Venom Antiserum Sales by Country (2016-2021) & (K Vials)
Table 31. Latin America Venom Antiserum Sales Market Share by Country (2016-2021)
Table 32. Latin America Venom Antiserum Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Venom Antiserum Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Venom Antiserum Sales by Country (2016-2021) & (K Vials)
Table 35. Middle East and Africa Venom Antiserum Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Venom Antiserum Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Venom Antiserum Revenue Market Share by Country (2016-2021)
Table 38. Global Venom Antiserum Sales (K Vials) by Type (2016-2021)
Table 39. Global Venom Antiserum Sales Market Share by Type (2016-2021)
Table 40. Global Venom Antiserum Revenue (Million US$) by Type (2016-2021)
Table 41. Global Venom Antiserum Revenue Share by Type (2016-2021)
Table 42. Global Venom Antiserum Price (USD/Vial) by Type (2016-2021)
Table 43. Global Venom Antiserum Sales (K Vials) by Application (2016-2021)
Table 44. Global Venom Antiserum Sales Market Share by Application (2016-2021)
Table 45. Global Venom Antiserum Revenue (Million US$) by Application (2016-2021)
Table 46. Global Venom Antiserum Revenue Share by Application (2016-2021)
Table 47. Global Venom Antiserum Price (USD/Vial) by Application (2016-2021)
Table 48. CSL Corporation Information
Table 49. CSL Description and Business Overview
Table 50. CSL Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 51. CSL Venom Antiserum Product
Table 52. CSL Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 56. Merck Venom Antiserum Product
Table 57. Merck Recent Developments/Updates
Table 58. BTG Corporation Information
Table 59. BTG Description and Business Overview
Table 60. BTG Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 61. BTG Venom Antiserum Product
Table 62. BTG Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 66. Pfizer Venom Antiserum Product
Table 67. Pfizer Recent Developments/Updates
Table 68. Haffkine Bio-Pharmaceutical Corporation Information
Table 69. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 70. Haffkine Bio-Pharmaceutical Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 71. Haffkine Bio-Pharmaceutical Venom Antiserum Product
Table 72. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 73. Rare Disease Therapeutics Corporation Information
Table 74. Rare Disease Therapeutics Description and Business Overview
Table 75. Rare Disease Therapeutics Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 76. Rare Disease Therapeutics Venom Antiserum Product
Table 77. Rare Disease Therapeutics Recent Developments/Updates
Table 78. Flynn Pharma Corporation Information
Table 79. Flynn Pharma Description and Business Overview
Table 80. Flynn Pharma Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 81. Flynn Pharma Venom Antiserum Product
Table 82. Flynn Pharma Recent Developments/Updates
Table 83. Vins Bioproducts Corporation Information
Table 84. Vins Bioproducts Description and Business Overview
Table 85. Vins Bioproducts Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 86. Vins Bioproducts Venom Antiserum Product
Table 87. Vins Bioproducts Recent Developments/Updates
Table 88. Bharat Serums and Vaccines Corporation Information
Table 89. Bharat Serums and Vaccines Description and Business Overview
Table 90. Bharat Serums and Vaccines Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 91. Bharat Serums and Vaccines Venom Antiserum Product
Table 92. Bharat Serums and Vaccines Recent Developments/Updates
Table 93. Serum Biotech Corporation Information
Table 94. Serum Biotech Description and Business Overview
Table 95. Serum Biotech Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 96. Serum Biotech Venom Antiserum Product
Table 97. Serum Biotech Recent Developments/Updates
Table 98. MicroPharm Corporation Information
Table 99. MicroPharm Description and Business Overview
Table 100. MicroPharm Venom Antiserum Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 101. MicroPharm Venom Antiserum Product
Table 102. MicroPharm Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Venom Antiserum Distributors List
Table 106. Venom Antiserum Customers List
Table 107. Venom Antiserum Market Trends
Table 108. Venom Antiserum Growth Drivers
Table 109. Venom Antiserum Market Restraints
Table 110. Global Venom Antiserum Sales Forecast by Type (2022-2027) & (K Vials)
Table 111. Global Venom Antiserum Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Venom Antiserum Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Venom Antiserum Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Venom Antiserum Sales Forecast by Application (2022-2027) & (K Vials)
Table 115. Global Venom Antiserum Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Venom Antiserum Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Venom Antiserum Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Venom Antiserum Sales Forecast by Region (2022-2027) & (K Vials)
Table 119. Global Venom Antiserum Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Venom Antiserum Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Venom Antiserum Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Venom Antiserum
Figure 2. Global Venom Antiserum Market Share by Type in 2020 & 2027
Figure 3. Polyvalent Product Picture
Figure 4. Monovalent Product Picture
Figure 5. Global Venom Antiserum Market Share by Application in 2020 & 2027
Figure 6. Hospitals and Clinics
Figure 7. Non-profit Institutions
Figure 8. Global Venom Antiserum Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Venom Antiserum Market Size 2016-2027 (US$ Million)
Figure 10. Global Venom Antiserum Sales 2016-2027 (K Vials)
Figure 11. Global Venom Antiserum Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Venom Antiserum Sales Share by Manufacturers in 2020
Figure 13. Global Venom Antiserum Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Venom Antiserum Players: Market Share by Revenue in 2020
Figure 15. Venom Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Venom Antiserum Sales Market Share by Region (2016-2021)
Figure 17. Global Venom Antiserum Sales Market Share by Region in 2020
Figure 18. Global Venom Antiserum Revenue Market Share by Region (2016-2021)
Figure 19. Global Venom Antiserum Revenue Market Share by Region in 2020
Figure 20. U.S. Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Venom Antiserum Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Venom Antiserum by Type (2016-2021)
Figure 45. Sales Market Share of Venom Antiserum by Application (2016-2021)
Figure 46. Sales Market Share of Venom Antiserum by Application in 2020
Figure 47. Revenue Share of Venom Antiserum by Application (2016-2021)
Figure 48. Revenue Share of Venom Antiserum by Application in 2020
Figure 49. Manufacturing Cost Structure of Venom Antiserum
Figure 50. Manufacturing Process Analysis of Venom Antiserum
Figure 51. Venom Antiserum Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed